Leroux-Roels I, Davis MG, Steenackers K, Essink B, et al. Safety and immunogenicity of a respiratory syncytial virus prefusion F (RSVPreF3) candidate vaccine in older adults: phase I/II randomized clinical trial. J Infect Dis 2022 Jul 29. pii: 6651941. doi: 10.1093.
PMID: 35904987